Advertisement

Quality of Life Research

, Volume 22, Issue 6, pp 1231–1238 | Cite as

Health-related quality of life and supportive care in patients with rare long-term neurological conditions

  • Melanie Calvert
  • Hardev Pall
  • Thomas Hoppitt
  • Benjamin Eaton
  • Edward Savill
  • Catherine Sackley
Brief Communication

Abstract

Purpose

Rare long-term neurological conditions (rLTNCs) may have significant impact on patients’ health-related quality of life (HRQL); however, evidence is sparse. We assessed HRQL and access to supportive care in patients with rLTNCs.

Methods

Survey of patients with rare rLTNCs (motor neurone disease, Huntington’s disease, cerebellar ataxia, progressive supranuclear palsy, multiple system atrophy, Charcot–Marie–Tooth disease and postpolio syndrome) to assess current access to health and social care, and HRQL using the Euroqol EQ-5D.

Results

A total of 266 participants with rLTNCs completed the survey. The HRQL of patients is substantially reduced compared to the general population. Many patients reported pain, were anxious or depressed and experienced problems with mobility, self-care and usual activities (mean EQ-5D index scores ranged from 0.2 to 0.44). Although some patients have accessed rehabilitative services, results suggest care coordination could be improved.

Conclusions

Rare long-term neurological conditions have a significant impact on HRQL. Many patients with rLTNCs do not seem to be accessing the level of health and social care services that could improve their HRQL.

Keywords

Health-related Quality of Life Long-term neurological conditions EQ-5D Service access 

Notes

Acknowledgments

The study was part of the RESULT study which was funded by the UK Department of Health Policy Research Programme. The authors thank Ms Helen Duffy for administrative support in preparation of the manuscript.

Conflicts of interest

No conflicts of interest are declared.

References

  1. 1.
    Sackley, C., Hoppitt, T., Calvert, M., Pall, H., Gill, P., Yao, G. et al. (2011). Review of epidemiology and service use in rare long-term neurological conditions (RESULT). Department of Health.http://www.ltnc.org.uk/download_files/final%20reports/Oct_11/RESULT_Final_Report.pdf. Accessed 17 Sept 2012.
  2. 2.
    Department of Health (2005). The National Service Framework for long term conditions. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4105369.pdf. Accessed 17 Sept 2012.
  3. 3.
    Neurological Alliance response to health white paper, Equity and Excellence: Liberating the NHS. Oct 2010. http://www.mstrust.org.uk/professionals/downloads/neurological_allaince_response_to_equity_excellence.pdf. Accessed 20 Mar 2012.
  4. 4.
    Department of Health Report by the Comptroller and Auditor General. HC1586, Session 2010-2012 (2011). Services for people with neurological conditions. 16th December 2011. The Stationery Office. http://www.official-documents.gov.uk/document/hc1012/hc15/1586/1586.pdf. Accessed 17 Sept 2012.
  5. 5.
    Aubeeluck, A., Buchanan, H., Stupple, E. ‘All the burden on all the carers’: Exploring quality of life with family care givers of Huntington’s disease patients. Quality of Life Research. November 2011 Epub ahead of print.Google Scholar
  6. 6.
    The Health Improvement Network (THIN) Database which collates data from 429 UK general medical practices. http://www.thin-uk.com/. Accessed 22 Mar 2012.
  7. 7.
    Brooks, R., & de Charro, F. (1996). EuroQol: the current state of play. Health Policy, 37(1), 53–72.PubMedCrossRefGoogle Scholar
  8. 8.
    Schrag, A., Selai, C., Davis, J., Lees, A. J., Jahanshahi, M., & Quinn, N. (2003). Health-related quality of life in patients with progressive supranuclear palsy. Movement Disorders, 18(12), 1464–1469.PubMedCrossRefGoogle Scholar
  9. 9.
    Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35, 1095–1108.PubMedCrossRefGoogle Scholar
  10. 10.
    Ose, D., Wensing, M., Szecsenyi, J., Joos, S., Hermann, K., & Miksch, A. (2009). Impact of primary care based disease management on the health-related quality of life in patients with type 2 diabetes and comorbidity. Diabetes Care, 32(9), 1594–1596.PubMedCrossRefGoogle Scholar
  11. 11.
    Pickard, A. S., Johnson, J. A., Feeny, D. H., Shuaib, A., Carriere, K. C., & Nasser, A. M. (2004). Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and health utilities index. Stroke, 35(2), 607–612.PubMedCrossRefGoogle Scholar
  12. 12.
    Haacke, C., Althaus, A., Spottke, A., Siebert, U., Back, T., & Dodel, R. (2006). Long-term outcome after stroke: Evaluating health-related quality of life using utility measurements. Stroke, 37(1), 193–198.PubMedCrossRefGoogle Scholar
  13. 13.
    Sobocki, P., Ekman, M., Agren, H., Krakau, I., Runeson, B., Mårtensson, B., et al. (2007). Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value in Health, 10(2), 153–160.PubMedCrossRefGoogle Scholar
  14. 14.
    Kind, P., Hardman, G., Macran, S. (1999). UK population norms for EQ-5D. University of York Centre for Health Economics, Discussion paper 172.Google Scholar
  15. 15.
    Green, C., Kiebert, G., Murphy, C., Mitchell, J. D., O’Brien, M., Burrell, A., et al. (2003). Patients’ health-related quality-of-life and health state values for motor neurone disease/amyotrophic lateral sclerosis. Quality of Life Research, 12(5), 565–574.PubMedCrossRefGoogle Scholar
  16. 16.
    Schrag, A., Geser, F., Stampfer-Kountchev, M., Seppi, K., Sawires, M., Kollennsperger, M., et al. (2006). Health-related quality of life in multiple system atrophy. Movement Disorders, 21(6), 809–815.PubMedCrossRefGoogle Scholar
  17. 17.
    Kiebert, G. M., Green, C., Murphy, C., Mitchell, J. D., O’Brien, M., Burrell, A., et al. (2001). Patients’ health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 191, 87–93.PubMedCrossRefGoogle Scholar
  18. 18.
    Schrag, A., Selai, C., Davis, J., Lees, A. J., Jahanshahi, M., & Quinn, N. (2003). Health-related quality of life in patients with progressive supranuclear palsy. Movement Disorders, 18(12), 1464–1469.PubMedCrossRefGoogle Scholar
  19. 19.
    Siderowf, A., Ravina, B., & Glick, H. A. (2002). Preference-based quality-of-life in patients with Parkinson’s disease. Neurology, 59(1), 103–108.PubMedCrossRefGoogle Scholar
  20. 20.
    Reuther, M., Spottke, E. A., Klotsche, J., Riedel, O., Peter, H., Berger, K., et al. (2007). Assessing health-related quality of life in patients with Parkinson’s disease in a prospective longitudinal study. Parkinsonism & Related Disorders, 13(2), 108–114.CrossRefGoogle Scholar
  21. 21.
    Jacqui, W. (2011). Services for people with neurological conditions are poor value for money. BMJ 343.Google Scholar
  22. 22.
    Signorello, L. B., McLaughlin, J. K., Lipworth, L., Friis, S., Sorensen, H. T., Blot, W. J. (2002). Confounding by indication in epidemiologic studies of commonly used analgesics. American Journal of Therapeutics 9(3).Google Scholar
  23. 23.
    Peters, M., Fitzpatrick, R., Doll, H., Playford, D., & Jenkinson, C. (2011). Does self-reported well-being of patients with Parkinson’s disease influence caregiver strain and quality of life? Parkinsonism & Related Disorders, 17(5), 348–352. Epub 2011 Feb 26.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Melanie Calvert
    • 1
  • Hardev Pall
    • 2
  • Thomas Hoppitt
    • 1
  • Benjamin Eaton
    • 1
  • Edward Savill
    • 1
  • Catherine Sackley
    • 1
  1. 1.School of Health and Population SciencesUniversity of BirminghamBirminghamUK
  2. 2.Clinical and Experimental MedicineUniversity of BirminghamBirminghamUK

Personalised recommendations